Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
17.29
-0.96 (-5.26%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Tvardi Therapeutics Market Cap
Tvardi Therapeutics has a market cap or net worth of $53.14 million as of April 17, 2025. Its market cap has increased by 7.13% in one year.
Market Cap
53.14M
Enterprise Value
n/a
1-Year Change
7.13%
Ranking
Category
Stock Price
$17.29
Market Cap Chart
Since January 31, 2014, Tvardi Therapeutics's market cap has decreased from $282.00M to $53.14M, a decrease of -81.16%. That is a compound annual growth rate of -13.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 77.90M | 178.21% |
| Dec 31, 2024 | 28.00M | -30.86% |
| Dec 29, 2023 | 40.50M | -92.98% |
| Dec 30, 2022 | 577.10M | -11.37% |
| Dec 31, 2021 | 651.10M | -13.65% |
| Dec 31, 2020 | 754.00M | 0.27% |
| Dec 31, 2019 | 752.00M | 46.65% |
| Dec 31, 2018 | 512.80M | 28.49% |
| Dec 29, 2017 | 399.10M | 57.44% |
| Dec 30, 2016 | 253.50M | -44.78% |
| Dec 31, 2015 | 459.10M | 102.16% |
| Dec 31, 2014 | 227.10M | -19.47% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.93B |
| UnitedHealth Group | 535.14B |
| Johnson & Johnson | 370.90B |
| AbbVie | 303.70B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 224.94B |
| AstraZeneca | 210.38B |
| Novartis AG | 210.23B |